TY - JOUR
T1 - Advances in monitoring cell-based therapies with magnetic resonance imaging
T2 - Future perspectives
AU - Ngen, Ethel J.
AU - Artemov, Dmitri
N1 - Funding Information:
The authors would like to thank Ms. Mary McAllister for editing this manuscript. This research was sponsored by the TEDCO Maryland Stem Cell Research Fund (2010-MSCRFE-0096) and the American Brain Tumor Association (ABTA) Basic Research Fellowship in honor of Joel A. Gringas (grant number: 117704).
Publisher Copyright:
© 2017 by the authors; licensee MDPI, Basel, Switzerland.
PY - 2017/1/19
Y1 - 2017/1/19
N2 - Cell-based therapies are currently being developed for applications in both regenerative medicine and in oncology. Preclinical, translational, and clinical research on cell-based therapies will benefit tremendously from novel imaging approaches that enable the effective monitoring of the delivery, survival, migration, biodistribution, and integration of transplanted cells. Magnetic resonance imaging (MRI) offers several advantages over other imaging modalities for elucidating the fate of transplanted cells both preclinically and clinically. These advantages include the ability to image transplanted cells longitudinally at high spatial resolution without exposure to ionizing radiation, and the possibility to co-register anatomical structures with molecular processes and functional changes. However, since cellular MRI is still in its infancy, it currently faces a number of challenges, which provide avenues for future research and development. In this review, we describe the basic principle of cell-tracking with MRI; explain the different approaches currently used to monitor cell-based therapies; describe currently available MRI contrast generation mechanisms and strategies for monitoring transplanted cells; discuss some of the challenges in tracking transplanted cells; and suggest future research directions.
AB - Cell-based therapies are currently being developed for applications in both regenerative medicine and in oncology. Preclinical, translational, and clinical research on cell-based therapies will benefit tremendously from novel imaging approaches that enable the effective monitoring of the delivery, survival, migration, biodistribution, and integration of transplanted cells. Magnetic resonance imaging (MRI) offers several advantages over other imaging modalities for elucidating the fate of transplanted cells both preclinically and clinically. These advantages include the ability to image transplanted cells longitudinally at high spatial resolution without exposure to ionizing radiation, and the possibility to co-register anatomical structures with molecular processes and functional changes. However, since cellular MRI is still in its infancy, it currently faces a number of challenges, which provide avenues for future research and development. In this review, we describe the basic principle of cell-tracking with MRI; explain the different approaches currently used to monitor cell-based therapies; describe currently available MRI contrast generation mechanisms and strategies for monitoring transplanted cells; discuss some of the challenges in tracking transplanted cells; and suggest future research directions.
KW - Cell-based therapies
KW - Cell-tracking
KW - Cellular MRI
KW - Environmentallyresponsive MRI biosensors
KW - MRI contrast agents
UR - http://www.scopus.com/inward/record.url?scp=85010739520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010739520&partnerID=8YFLogxK
U2 - 10.3390/ijms18010198
DO - 10.3390/ijms18010198
M3 - Review article
C2 - 28106829
AN - SCOPUS:85010739520
SN - 1661-6596
VL - 18
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 1
M1 - 198
ER -